BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3172555)

  • 1. [Detection of anti-horse serum antibody produced by injecting an antivenin or antitoxin (Report 2)].
    Ameno S; Ameno K; Fuke C; Kiryu T; Sogo K; Yodoya J; Ijiri I; Tsunenari S
    Nihon Hoigaku Zasshi; 1988 Apr; 42(2):161-8. PubMed ID: 3172555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of anti-horse serum antibody produced by injecting antivenin or antitoxin (Report 1)].
    Ameno S; Fuke C; Sogo K; Tsunenari S
    Nihon Hoigaku Zasshi; 1987 Jun; 41(3):224-31. PubMed ID: 3682296
    [No Abstract]   [Full Text] [Related]  

  • 3. Venomous snakebite in a patient allergic to horse serum.
    Otten EJ; McKimm D
    Ann Emerg Med; 1983 Oct; 12(10):624-7. PubMed ID: 6625264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Habu toxoid--from the view point of public health center].
    Uda H; Tomari T; Yanagihashi T; Nozaki M; Kodama K
    Nihon Koshu Eisei Zasshi; 1993 Jun; 40(6):482-90. PubMed ID: 8347864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the lethal effect of snake venom by serum of the opossum, Didelphis marsupialis.
    Werner RM; Faith RE
    Lab Anim Sci; 1978 Dec; 28(6):710-3. PubMed ID: 750730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Titration of antitetanus antibodies by enzyme immunoassay. Statistical studies for validation].
    German-Fattal M; Le Page C; German A; Rabaron A; Bizzini B
    Ann Pharm Fr; 1987; 45(1):5-14. PubMed ID: 3662342
    [No Abstract]   [Full Text] [Related]  

  • 10. [Agkistrodon halys bite treated with specific antivenin: discussion on 665 cases (author's transl)].
    Zhonghua Wai Ke Za Zhi; 1980 Dec; 18(6):568-9. PubMed ID: 7238225
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral immune response of patients bitten by the snake Bothrops erythromelas.
    Luna KP; Xavier EM; Pascoal VP; Martins-Filho OA; Pereira VR
    Rev Soc Bras Med Trop; 2010; 43(6):731-2. PubMed ID: 21181034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The improvement of the therapeutic anti-Lachesis muta serum production in horses.
    Stephano MA; Guidolin R; Higashi HG; Tambourgi DV; Sant'Anna OA
    Toxicon; 2005 Mar; 45(4):467-73. PubMed ID: 15733568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys.
    Tapia MD; Pasetti MF; Cuberos L; Sow SO; Doumbia MN; Bagayogo M; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2006 Sep; 25(9):819-25. PubMed ID: 16940841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of maternally derived immunity to tetanus and response in newborn foals given tetanus antitoxin.
    Liu IK; Brown SL; Kuo J; Neeley DP; Feeley JC
    Am J Vet Res; 1982 Nov; 43(11):2019-22. PubMed ID: 7181201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of tetanus-antitoxin in the horse with enzyme-linked immunosorbent assay (ELISA)].
    Fey H; Stiffler-Rosenberg G
    Schweiz Arch Tierheilkd; 1977 Nov; 119(11):437-46. PubMed ID: 594740
    [No Abstract]   [Full Text] [Related]  

  • 17. Rattlesnake bites in southern California and rationale for recommended treatment.
    Wingert WA; Chan L
    West J Med; 1988 Jan; 148(1):37-44. PubMed ID: 3277335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful venomous snakebite neutralization with massive antivenin infusion in a child.
    J Trauma; 1985 May; 25(5):464-5. PubMed ID: 3999174
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual localization of snakebite treated without antivenin: case report.
    Satar S; Karcioglu O; Sebe A
    Mt Sinai J Med; 2005 Mar; 72(2):116-9. PubMed ID: 15770341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetanus antitoxin seroprevalence in patients with Behçet's disease.
    Ayaslioglu E; Erkek E; Kiliç D; Kaygusuz S; Karaca F; Düzgün N
    Scand J Infect Dis; 2003; 35(5):299-301. PubMed ID: 12875513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.